🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Papers
Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2021.10.044Source: DataRank Database

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression is a research paper published in Journal of the American College of Cardiology (2022). On theSindex it has a DataRank of 0. It has been cited 194 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access194 citations

Cite:

Linked data & code

Additional file 1 of Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease · figshare
Additional file 1 of Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease · figshare
Additional file 1 of Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study · figshare
Additional file 1 of Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study · figshare
Additional file 1 of Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents? · figshare
Additional file 1 of Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents? · figshare

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: hybridTopics (27)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

FFindable (2/2)

Has DOI
Indexed in repositories

AAccessible (1/2)

Open Access

IInteroperable (2/2)

DataCite relations
Linked datasets

RReusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Marwa Daghem ORCID,Evangelos Tzolos ORCID,Mohammed N. Meah ORCID,Mhairi Doris ORCID,Alastair J. Moss ORCID

Live enrichment

PubMed:35057907 PMC:PMC8784819

British Heart Foundation

Grant: FS/19/46/34445

National Heart and Lung Institute

Grant: 1R01HL151266

British Heart Foundation

Grant: CH/09/002/26360

NHLBI NIH HHS

Grant: R01 HL148787

British Heart Foundation

Grant: FS/CRTF/20/24086

National Heart and Lung Institute

Grant: 1R01HL148787-01A1

Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT Angiography

British Heart Foundation

Grant: FS/14/78/31020

British Heart Foundation

Grant: FS/17/79/33226

British Heart Foundation

Grant: FS/ICRF/20/26002

National Institutes of Health

Grant: 5R01HL151266-02

Effect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CAD

Novartis

Pfizer

National Institutes of Health

hybridLicense: cc-by

publisherhttps://www.sciencedirect.com/science/article/pii/S0735109721081870/pdf

repositoryhttps://research.vumc.nl/en/publications/098280a7-f677-4e77-845b-3f6952556a49

repositoryhttps://pure.amsterdamumc.nl/ws/files/176688954/Association-of-lipoproteina-with-atherosclerotic-plaque-progression.pdf

repositoryhttps://pure.amc.nl/en/publications/association-of-lipoproteina-with-atherosclerotic-plaque-progression(6edf21f2-bdc3-4a19-a5b2-6fb50c8b73b4).html

repositoryhttps://dspace.library.uu.nl/handle/1874/445363

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansDisease ProgressionLipoprotein(a)Coronary AngiographyAgedFemaleMaleCoronary Artery DiseasePlaque, AtheroscleroticBiomarkersComputed Tomography Angiography

Keywords

Lipoprotein(a)Coronary Computed Tomography AngiographyLow-attenuation PlaqueMaleComputed Tomography AngiographyCoronary Artery DiseaseCoronary AngiographyPlaque, AtheroscleroticDisease ProgressionHumansFemaleBiomarkersOriginal InvestigationAged

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease

10.6084/m9.figshare.21522073.v1figshare

Additional file 1 of Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease

10.6084/m9.figshare.21522073figshare

Additional file 1 of Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study

10.6084/m9.figshare.21546685.v1figshare

Additional file 1 of Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study

10.6084/m9.figshare.21546685figshare

Additional file 1 of Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents?

10.6084/m9.figshare.26945925figshare

Additional file 1 of Is lipoprotein(a) measurement important for cardiovascular risk stratification in children and adolescents?

10.6084/m9.figshare.26945925.v1figshare

Related Papers (10)

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

European Heart Journal(2022)

co-cited

10.1093/eurheartj/ehac361

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

N/A

1.4DataRank · unranked

European Heart Journal(2019)

co-cited

10.1093/eurheartj/ehz455

Lipoprotein(a) Testing Patterns in a Large Health System

The American Journal of Cardiology(2021)

co-cited

10.1016/j.amjcard.2021.05.018

Emerging RNA Therapeutics to Lower Blood Levels of Lp(a)

Journal of the American College of Cardiology(2021)

co-citedsame journal

10.1016/j.jacc.2021.01.051

PCSK9 Inhibition and Oxidized Phospholipids

Journal of the American College of Cardiology(2021)

co-citedsame journal

10.1016/j.jacc.2021.07.031

Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins

Journal of the American College of Cardiology(2024)

co-citedsame journal

10.1016/j.jacc.2023.09.836

Particle Number and Characteristics of Lipoprotein(a), LDL, and apoB

Journal of the American College of Cardiology(2024)

co-citedsame journal

10.1016/j.jacc.2023.11.008

Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort

Journal of clinical lipidology(2020)

co-cited

10.1016/j.jacl.2020.06.010

Non-genetic influences on lipoprotein(a) concentrations

Atherosclerosis(2022)

co-cited

10.1016/j.atherosclerosis.2022.04.006

Lipoprotein(a), platelet function and cardiovascular disease

Nature Reviews Cardiology(2023)

co-cited

10.1038/s41569-023-00947-2